BLCO - Bausch & Lomb Corp
17.06
-0.540 -3.165%
Share volume: 357,913
Last Updated: 03-06-2026
Medical Equipment/Ophthalmic Goods:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$17.60
-0.54
-0.03%
Fundamental analysis
50%
Profitability
42%
Dept financing
50%
Liquidity
8%
Performance
69%
Performance
5 Days
-5.12%
1 Month
0.89%
3 Months
3.02%
6 Months
9.92%
1 Year
7.30%
2 Year
4.47%
Key data
Stock price
$17.06
DAY RANGE
$16.87 - $17.34
52 WEEK RANGE
$10.45 - $18.92
52 WEEK CHANGE
$7.30
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
Company detail
CEO: Joseph C. Papa
Region: US
Website: bausch.com
Employees: 12,500
IPO year: 2022
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing
Region: US
Website: bausch.com
Employees: 12,500
IPO year: 2022
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing
Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life.Our business was founded in 1853 and incorporated in the State of New York in 1908 (“Old Bausch + Lomb”). Our executive offices are located at 520 Applewood Crescent, Vaughan, Ontario, Canada.
Recent news